Government supports expansion of Trajan's Victorian facility

Government supports expansion of Trajan's Victorian facility

April 17, 2019

Melbourne, Victoria, Australia

Trajan Scientific and Medical (Trajan) welcomed Minister for Jobs, Innovation and Trade, Martin Pakula at Trajan’s global corporate headquarters in Melbourne today to announce a grant supporting advanced scientific manufacturing in Victoria.

Trajan plans to invest circa A$2.4M into its Melbourne facility, with support from the Victorian Government over the next three years to meet growing global demand for its scientific products and technologies.

Stephen Tomisich, CEO, Trajan Scientific and Medical, says “We are pleased to engage the support of the Victorian Government, highlighting growth areas where Trajan is developing new devices and technologies to improve measurements for healthcare, food and environmental analysis.”

Trajan’s production will be scaled up through investment in sophisticated automation, manufacturing equipment, upskilling staff, and creation of new roles.

“Through continued investment into our team and infrastructure, the advanced manufacturing capability of our Melbourne facility is becoming a global benchmark for precision scientific technologies.” said Mr Tomisich.

This investment complements Trajan’s other centers of excellence, including unique polymer tubing extrusion operations in San Diego, USA; polymer production in Bethel, USA; glass manufacturing of analytical syringes and inlet liners in Penang, Malaysia, as well as Austin, USA.

Mr Tomisich said “At the heart of Trajan’s success is people - we firmly believe in developing our expertise in-house at all of our manufacturing and commercial locations around the world, as well as establishing relationships with partners that align with our commitment to improve human wellbeing.”

Trajan has a strong record of engagement with industry, academic and government partners around the globe, developing innovative analytical technologies and integrated laboratory workflow solutions.

“It’s about working together to translate scientific technologies to benefit people.” said Mr Tomisich.

Quotes attributable to Minister for Jobs, Innovation and Trade Martin Pakula

“We’re proud to be supporting local innovation, and improving patient care every step of the way.”

“Trajan’s choice to further develop its global HQ in Melbourne and expand its local manufacturing capability will strengthen Victoria’s global reputation as a thriving hub for biotechnology and pharmaceuticals.”

Photo: Mr Robert Lyon, Head of Corporate Development, Trajan Scientific and Medical, The Hon. Martin Pakula, Minister for Jobs, Innovation and Trade, Victorian Government, Mr Stephen Tomisich, Chief Executive Officer, Trajan Scientific and Medical, Dr Andrew Gooley, Chief Scientific Officer, Trajan Scientific and Medical, at Trajan’s global corporate headquarters in Melbourne, Australia.
Photo: Mr Robert Lyon, Head of Corporate Development, Trajan Scientific and Medical, The Hon. Martin Pakula, Minister for Jobs, Innovation and Trade, Victorian Government, Mr Stephen Tomisich, Chief Executive Officer, Trajan Scientific and Medical, Dr Andrew Gooley, Chief Scientific Officer, Trajan Scientific and Medical, at Trajan’s global corporate headquarters in Melbourne, Australia.

Photo: The Hon. Martin Pakula, Minister for Jobs, Innovation and Trade, Victorian Government, welcomed by Mr Stephen Tomisich, Chief Executive Officer, Trajan Scientific and Medical.
Photo: The Hon. Martin Pakula, Minister for Jobs, Innovation and Trade, Victorian Government, welcomed by Mr Stephen Tomisich, Chief Executive Officer, Trajan Scientific and Medical.

Photo: Demonstration of hemaPEN by Ms Lada Staskova, RMIT Master of Applied Chemistry (by research) student and intern at Murdoch Children’s Research institute (MCRI), and Dr Wei Boon (Jason) Hon, Research Scientist and Blood Lab Manager, Trajan Scientific and Medical; presented by Dr Andrew Gooley, Chief Scientific Officer, Trajan Scientific and Medical.
Photo: Following the announcement, there was a demonstration of Trajan's hemaPEN by Ms Lada Staskova, RMIT Master of Applied Chemistry (by research) student and intern at Murdoch Children’s Research institute (MCRI), and Dr Wei Boon (Jason) Hon, Research Scientist and Blood Lab Manager, Trajan Scientific and Medical; presented by Dr Andrew Gooley, Chief Scientific Officer, Trajan Scientific and Medical.

Media coverage
YouTube - Nine News Melbourne (17 April 2019): Trajan coverage 50:29-52:26

Download
Trajan press release [PDF]
Victorian Government, Australia, media release - Global Medtech Manufacturer Expands In Melbourne [PDF]

More information
Victorian Government, Australia - Global Medtech Manufacturer Expands In Melbourne
Trajan company history
Trajan facilities
hemaPEN

Media contact information
Trajan Scientific and Medical
Tel: +44 (0) 1908 568 844
media@trajanscimed.com




Also in News

CE mark for Trajan’s hemaPEN blood microsampling device, now available for diagnostic use across EU and UK
CE mark for Trajan’s hemaPEN blood microsampling device, now available for diagnostic use across EU and UK

May 07, 2020

Trajan Scientific and Medical has declared hemaPEN® compliance with EU IVD Directive 98/79/EC, and its release for in vitro diagnostic use in the EU and UK. This follows the hemaPEN’s recent addition to the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class 1 IVD device.

Read More

New Trajan microtome blades, for any tissue type
New Trajan microtome blades, for any tissue type

April 28, 2020

Trajan Scientific and Medical releases new microtome blades in Australia, New Zealand, UK and EU, to provide the blade of choice for any tissue type. For histologists who have trouble finding a blade that offers both exceptional cutting and longevity, Trajan microtome blades have been designed to enable smooth and precise sectioning across a wide range of tissue specimens.

Read More

The third leg in at-home healthcare – microsampling
The third leg in at-home healthcare – microsampling

April 16, 2020

Blood microsampling technology has been evolving over the past few years. Designed to cut the need for central pathology collection centers and trained phlebotomists. It enables the collection of very small, accurate blood samples in the home.

Read More